What Researchers Did
Researchers reviewed ten years of published studies on add-on treatments used alongside standard care for medication-related osteonecrosis of the jaw (MRONJ), a bone condition linked to certain osteoporosis and cancer drugs.
What They Found
This literature review looked at how much research exists on several adjunctive treatments for MRONJ, including platelet concentrates (PRP, PRGF, PRF), hyperbaric oxygen (HBO), fluorescence-guided bone surgery, drugs like teriparatide or pentoxifylline with tocopherol, PET imaging, laser therapy, and ozone therapy. The abstract states the review's goal was to evaluate the quantity and quality of scientific studies on this topic, not to measure how well any treatment worked. No sample sizes, success rates, or other outcome figures are reported for any of these treatments, including HBO.
What This Means for Canadian Patients
This review does not show whether hyperbaric oxygen or any other adjunctive treatment improves outcomes for MRONJ. It only describes that these treatments have been studied to varying degrees, with the stated aim of assessing how much and how good that research is. Patients considering add-on therapies for MRONJ should know this abstract does not report whether any of them work.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a literature review, not original research, and by its own stated aim it evaluated only the quantity and quality of existing studies rather than reporting outcome data for any of the treatments it discusses.